UNCY

UNICYCIVE THERAPEUTICS INC

Healthcare | Micro Cap

-$0.31

EPS Forecast

$1.66

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.31

Revenue Forecast:

$1.66

EPS Surprise Forecast:

$0.019

Revenue Surprise Forecast:

-$1

Post-release price volatility - Very high

Post-release Overnight Move:

±10.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

59%

Probability of beating revenue consensus:

37%

Probability of beating both EPS & revs consensus:

27%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.75

Earnings volatility

EPS standard deviation:

$0.21

Revenue standard deviation:

$5

As % of share price:

5.11% EXTREME UNCERTAINTY

As % of market cap:

4.55% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.07

Revenue 95th %ile:

$7

EPS 75th %ile:

-$0.24

Revenue 75th %ile:

$3

EPS 25th %ile:

-$0.37

Revenue 25th %ile:

$0

EPS 5th %ile:

-$0.57

Revenue 5th %ile:

-$3

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

35% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

40% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$50

Bid-ask per Share:

$0.02